ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
0 hedge funds and large institutions have $0 invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $1K → $0 (-$1K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Edge Wealth Management
New York
|
-$1K |
ECTE Hedge Fund Activity: Q1 2018 in Review
0 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q1 2018, worth a combined $0 — down 100% from $1K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ECTE and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Edge Wealth Management, exiting entirely with an estimated $1K sold.
- 0 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q1 2018, down from 2 in Q4 2017.
- Funds reported $0 of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q1 2018, down 100% quarter-over-quarter.
- 0 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q1 2018 and 2 closed out, a net change of -2 holders.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) seller in Q1 2018 was Edge Wealth Management, an estimated $1K sold.
Based on aggregated 13F filings for Q1 2018.